2021-11-16-世界卫生组织-Cervical_cancer_Eritrea_2021_country_profile_1页_64kb

Eritrea Cervical Cancer Profile Summary

Morbidty and Mortality

• In 2020, cervical cancer incidence rate was 10.1 per 100,000 women, with an age-standardized rate of 15.3.
• Cumulative risk by age 74 was 1.8%, and in 2019, 12,400 female deaths occurred, yielding a mortality-to-incidence ratio of 0.73%.
• No population-based cancer registry existed by 2021.

Primary Prevention

• HPV vaccination coverage was low, with less than 1% of girls targeted, and the program not integrated into the national schedule.
• Other factors: Tobacco use prevalence among women aged 15+ was 1.8%, but data on condom use, HIV incidence, and other risk factors were limited or not available.

Secondary Prevention Screening

• There was no national cervical cancer screening program, and primary screening use was limited.
• Screening coverage was weak, with only 8% of women aged 30-49 screened in the last 5 years and fewer than 10% ever screened.

Treatment and Supportive Care

• No national guidelines existed, and treatment infrastructure was inadequate, with few radiotherapy, brachytherapy, and medical staffing resources.
• Missing specialists included radiation oncologists, radiologists, and pathologists, indicating poor access to comprehensive cancer care.

WHO Cervical Cancer Elimination Strategy (2030 Targets)

• Eritrea did not meet key indicators, including HPV vaccination (<1% coverage) and screening uptake (<10%), highlighting gaps in prevention and control efforts.